GSM (Genito-Urinary Syndrome of Menopause) is an increasing problem of women worldwide. According to the North American Menopause Association, by 2025, the number of post-menopausal women will approach 1.1 billion. More than half of this number will experience vulvovaginal symptoms that will drastically change their lifestyle, senses, and sex life.
After menopause, changes in hormones cause the vaginal wall to become thinner, drier, less elastic, and more inflamed. FemiLift rejuvenates and thickens the vaginal wall, increasing natural lubrication. The treatment improves sexual function by reducing uncomfortable symptoms such as itching, burning and friction.